Distigmine Bromide and Post-Prostatectomy Voiding
| Autor: | N. A. Green, M. H. Ashken, P. J. R. Shah, Ann Wiles, R. G. Choa, C. G. C. Gaches, Paul Abrams |
|---|---|
| Rok vydání: | 1983 |
| Předmět: |
Male
Urology medicine.medical_treatment Pyridinium Compounds urologic and male genital diseases Placebo chemistry.chemical_compound Double-Blind Method Bromide medicine Humans Normal voiding Post prostatectomy Aged Prostatectomy Distigmine Clinical Trials as Topic business.industry Urination Disorders female genital diseases and pregnancy complications Detrusor function Urodynamics chemistry Anesthesia Bladder volume Urinary Catheterization business medicine.drug |
| Zdroj: | British Journal of Urology. 55:229-232 |
| ISSN: | 1464-410X 0007-1331 |
| DOI: | 10.1111/j.1464-410x.1983.tb06563.x |
| Popis: | Summary— Distigmine bromide (Ubretid) is a long-acting anticholinesterase which is thought to improve detrusor function, restoring normal voiding patterns which may have been disturbed by autonomic overactivity, particularly after surgery. Ninety-three patients entered a double-blind study of the effect of distigmine bromide versus placebo on voiding after prostatectomy. The results demonstrated that there was a trend towards improvement but no statistically significant increase in post-operative flow rates, in reduction in bladder volume, and in the incidence of re-catheterisation in the patients treated with distigmine bromide. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text